Home >> IPO >> GSP Crop Science IPO : GMP, Price, Analysis, And Details
GSP Crop Science IPO : GMP, Price, Analysis, And Details
GSP Crop Science IPO- Company Analysis
GSP Crop Science IPO under the Mainboard IPO category is a bookbuild issue of Rs. 400 Cr by GSP Crop Science Limited, and is an agrochemical company that produces fungicides, insecticides, herbicides, and plant growth regulators.
With formulations (active ingredients and additives) and technicals (concentrated active ingredients) for efficient pest, weed, and disease control, the company offers crop protection solutions to help farmers boost production. In order to satisfy client demands, the company develops, produces, supplies, and distributes a wide range of in-house-made agrochemicals that offer crop protection solutions.
GSP Crop Science IPO Details
The GSP Crop Science IPO date of opening is 16 Mar 2026, its initial public offering will end on 18 Mar, IPO allotment on Mar 20 and refund initiation on Mar 23, 2026.
The Rs. 400 crore new Mainboard IPO comprises a combination of a fresh issue of 0.75 crore shares (Rs. 240.00 crores) and offer for sale of 0.50 crore shares (Rs. 160.00 crores).
The GSP Crop Science IPO listing date (expected) might be on Tuesday, March 24, 2026, and listing at the BSE and NSE.
The GSP Crop Science IPO price band is Rs. 304 to Rs. 320.
IPO Timetable (Tentative)
|
Events |
Date |
|
IPO Opening Date |
Mar 16, 2026 |
|
IPO Closing Date |
Mar 18, 2026 |
|
IPO Allotment Date |
Mar 20, 2026 |
|
Refund Initiation |
Mar 23, 2026 |
|
IPO Listing Date |
Mar 24, 2026 |
Industry Overview
Click to open demat account and apply for the IPO.
Company Financials
(Amount in Cr)
|
Particulars |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
1,228.50 |
980.34 |
1,132.13 |
|
Total Income |
1,301.06 |
1,158.23 |
1,206.05 |
|
Profit After Tax |
81.42 |
55.54 |
17.57 |
|
EBITDA |
164.03 |
130.41 |
81.28 |
|
NET Worth |
450.03 |
370.46 |
363.47 |
|
Reserves and Surplus |
411.02 |
344.46 |
336.00 |
|
Total Borrowing |
295.60 |
235.44 |
324.26 |
Cash Flows
(Amount in lac)
|
Net Cash Flow |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Net Cash Flow Operating Activities |
40.88 |
(115.91) |
140.72 |
|
Net Cash Flow Investing Activities |
- |
(0.08) |
(22.73) |
|
Net Cash Flow Financing Activities |
- |
92.45 |
(1.67) |
Revenue Bifurcation
(Rs. in Lac)
(Source: RHP)
The Objective of the Issue
The company desires to use the Net Proceeds from the Issue to fulfill its following goals:
Repayment or pre-payment, in part or full, of all or certain borrowings availed by the Company. ~ Rs. 170 Cr.
Listed Peers of GSP Crop Science Ltd.
|
Name of Company |
Face Value (Rs. ) |
Basic EPS (Rs. ) |
PE Ratio (x) |
|
PI Industries Limited |
1.00 |
109.44 |
28.25 |
|
Sumitomo Chemical India Limited |
10.00 |
10.13 |
39.23 |
|
Dhanuka Agritech Limited |
2.00 |
65.55 |
15.13 |
|
Rallis India Limited |
1.00 |
6.43 |
40.12 |
|
Bharat Rasayan Limited |
10.00 |
339.14 |
4.14 |
|
India Pesticides Limited |
1.00 |
7.14 |
21.57 |
|
Excel Industries Limited |
5.00 |
67.87 |
13.13 |
|
Heranba Industries Limited |
10.00 |
0.77 |
252.92 |
Valuation
|
KPI |
Value |
|
ROE |
18.38% |
|
ROCE |
19.80% |
|
Debt/Equity |
0.58 |
|
PAT Margin |
6.26% |
|
EBITDA Margin |
12.74% |
|
Price to Book Value |
2.77 |
Evaluation of P/E Ratio
Considering the period ended on FY 2025 with an EPS of Rs. 21.20 from the last year, the resulting P/E ratio is 15.09x.
Explore the Novus Loyalty IPO.
IPO's Strengths
- With a broad spectrum of insecticides, herbicides, fungicides, and plant growth regulators in our well-diversified product line, we offer our clients a complete solution.
- Serving a sizable and varied clientele both at home and abroad.
- Strong internal R&D capability with an emphasis on product development and innovation
- Strong production facilities that can produce a variety of goods with an emphasis on sustainability.
- Under the direction of skilled and knowledgeable promoters and assisted by a competent management team.
IPO's Weaknesses
- Regulatory Approval & Licensing Risk
- Quality & Technical Compliance Risk
- Distribution Network Dependency Risk.
GSP Crop Science IPO GMP (Grey Market Premium)
GSP Crop Science IPO GMP today has not started yet as of 12 Mar 2026 while writing this information.
GSP Crop Science IPO Summary
|
IPO Opening & Closing Date |
16 Mar, 2026 to 18 Mar, 2026 |
|
Face Value |
Rs. 10 per Share |
|
Issue Price |
Rs. 304 to Rs. 320 per Share. |
|
Lot Size |
46 Shares |
|
Issue Size |
1,25,00,000 Shares (Rs. 400 Cr) |
|
Offer for Sale |
50,00,000 Shares (Rs. 160 Cr) |
|
Fresh Issue |
75,00,000 Shares (Rs. 240 Cr) |
|
Listing at |
BSE, NSE |
|
Issue Type |
Bookbuild issue IPO |
|
Registrar |
MUFG Intime India Pvt. Ltd. |
IPO Lot Details
|
Minimum Lot Investment (Retail) |
1 Lot |
|
Maximum Lot Investment (Retail) |
13 Lots |
|
HNI (Min) |
14 Lots |
GSP Crop Science IPO Allotment Status
To check the GSP Crop Science IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.
Using BSE Website - BSE IPO allotment status
Promoters And Management of GSP Crop Science Ltd.
- Bhavesh Vrajmohan Shah
- Tirth Kenal Shah
- Vilasben Vrajmohan Shah
- Falguni Kenal Shah
- Alpha Trust
- Kappa Trust
|
Pre-Issue Promoter Shareholding |
98.32% |
|
Post-Issue Promoter Shareholding |
- |
IPO Lead Managers
- Equirus Capital Pvt. Ltd.
Dividend Policy
The company has paid a dividend of Rs. 0.75 per equity share in the FY25.
Conclusion
GSP Crop Science Limited's IPO in the agrochemical sector is an intriguing mainboard issue, with a solid product portfolio and increasing financial performance. The company's valuation is approximately 15x P/E when compared to its listed peers. Investors assess each company's growth prospects, debt load, and outlook for the agrochemical business.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the company, click here to download the DRHP.
Click Here To Stay Updated With The Upcoming IPOs.
DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
